Literature DB >> 25499901

Continuous tissue glucose monitoring correlates with measurement of intermittent capillary glucose in patients with distributive shock.

D Ballesteros1, Ó Martínez2, R Blancas Gómez-Casero2, C Martín Parra2, B López Matamala2, B Estébanez2, M Chana2.   

Abstract

BACKGROUND: Intermittent glycemic measurements in patients admitted to the intensive care unit (ICU) can result in episodes of severe hypoglycemia or in a poor control of glycemia range. We designed a study to assess accuracy and reliability of continuous monitoring of tissue glucose for patients with distributive shock.
METHODS: Consecutive patients admitted to the ICU with a diagnosis of distributive shock and the need of insulin infusion for glycemic control were included in the study. These patients were implanted a Continuous Glucose Control Monitoring System (CGMS) with the sensor inserted subcutaneously into the abdominal wall. CGMS values were recorded every 5min. Capillary glucose (CG) was monitored for adjusting insulin perfusion according to the ICU protocol. Correlation between both methods was assessed.
RESULTS: A total of 11,673 CGMS and 348 CG values were recorded. In five patients, CGMS failed to detect tissue glucose. A glucose value <3.33mmol/l (<60mg/dl) was observed in 3.6% of CGMS and in 0.29% CG values. 295 pairs of measurements were included in the statistical analysis for correlation assessment. The intraclass correlation coefficient was 0.706. The Pearson correlation coefficient was 0.71 (p<0.0001, 95% CI 0.65-0.76). The mean of differences between both measurement methods was 0.22mmol/l (3.98mg/dl) (95% CI 0.66-7.31).
CONCLUSIONS: When the Continuous Glucose Control Monitoring System (CGMS) is able to obtain data (75% of the patients), there is correlation between the values obtained by this method and capillary blood glucose in patients with distributive shock. CGMS can detect more episodes of glycemic excursions outside the normal range than intermittent capillary glucose monitoring. Variables that may impair glucose metabolism and peripheral soft tissues perfusion could impair CGMS measurements.
Copyright © 2014 Elsevier España, S.L.U. and SEMICYUC. All rights reserved.

Entities:  

Keywords:  Capillary glucose; Critical illness; Distributive shock; Enfermo crítico; Glucosa capilar; Glucosa tisular; Glucose monitoring; Hipoglucemia; Hypoglycemia; Monitorización de la glucosa; Shock distributivo; Tissue glucose

Mesh:

Substances:

Year:  2014        PMID: 25499901     DOI: 10.1016/j.medin.2014.09.004

Source DB:  PubMed          Journal:  Med Intensiva        ISSN: 0210-5691            Impact factor:   2.491


  5 in total

1.  Glucose Management Technologies for the Critically Ill.

Authors:  Pedro D Salinas; Carlos E Mendez
Journal:  J Diabetes Sci Technol       Date:  2019-01-13

Review 2.  Inpatient Continuous Glucose Monitoring and Glycemic Outcomes.

Authors:  David L Levitt; Kristi D Silver; Elias K Spanakis
Journal:  J Diabetes Sci Technol       Date:  2017-03-14

3.  Novel Glycemic Index Based on Continuous Glucose Monitoring to Predict Poor Clinical Outcomes in Critically Ill Patients: A Pilot Study.

Authors:  Eun Yeong Ha; Seung Min Chung; Il Rae Park; Yin Young Lee; Eun Young Choi; Jun Sung Moon
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-04       Impact factor: 6.055

4.  Continuous Glucose Monitors and Automated Insulin Dosing Systems in the Hospital Consensus Guideline.

Authors:  Rodolfo J Galindo; Guillermo E Umpierrez; Robert J Rushakoff; Ananda Basu; Suzanne Lohnes; James H Nichols; Elias K Spanakis; Juan Espinoza; Nadine E Palermo; Dessa Garnett Awadjie; Leigh Bak; Bruce Buckingham; Curtiss B Cook; Guido Freckmann; Lutz Heinemann; Roman Hovorka; Nestoras Mathioudakis; Tonya Newman; David N O'Neal; Michaela Rickert; David B Sacks; Jane Jeffrie Seley; Amisha Wallia; Trisha Shang; Jennifer Y Zhang; Julia Han; David C Klonoff
Journal:  J Diabetes Sci Technol       Date:  2020-09-28

Review 5.  Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital.

Authors:  Guillermo E Umpierrez; David C Klonoff
Journal:  Diabetes Care       Date:  2018-06-23       Impact factor: 19.112

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.